Human B lymphocyte antigens analogous to the murine Ta determinants were found on myeloblasts and promyelocytes but not on more mature granulocytes. This was apparent by fluorescent staining with both human alloantisera and rabbit antisera to the isolated Ta-like proteins. Considerable interest has recently been directed to the membrane glycoproteins that contain the major antigenic determinants that characterize the B lymphocyte and aid in distinguishing these cells from T lymphocytes. These B cell components were initially recognized through alloantibodies contained in postpartum sera (1) and more recently with heteroantisera raised against purified preparations isolated from B cell membranes by enzyme (2, 3) or detergent (4) solubilization. This system of lymphocyte determinants primarily expressed on B cells has many analogies to the murine I-region antigen (Ia) system and thus has been termed "Ia-like"; however, for simplicity the term "Ta" will be used in this paper. As with the murine Ta antigens, the human Ta antigens are constituents of the histocompatibility system and relate closely to determinants that are recognized in the mixed lymphocyte culture reaction. The murine Ta antigens also are characteristic of B cells but in addition have been demonstrated on T cells by special procedures. Thus far, these antigens have not been detected on human T cells by the fluorescence or cytotoxic methods generally used. Indeed, this selective expression is proving to be a marker of considerable utility and significance in various studies on human lymphocytes (4, 5) . However, from the initial studies it was clear that certain nonlymphoid cells bore similar antigenic determinants (1).
patients with chronic myelocytic leukemia showed this difference especially clearly. Separation of the myeloblasts and promyelocytes by multistep density gradient fractionation produced a marked enrichment of the positive cells. The remaining cells from higher density fractions were more-mature neutrophils that were essentially negative. In acute myeloid leukemia, in which myeloid cells early in differentiation predominate, the vast majority of cells were strongly positive. Similar results were obtained with normal bone marrow cells. Here also, only the early forms of the myeloid series separated by gradient centrifugation had Ta antigens. Evidence was also obtained for the presence of Ta determinants on cells with the appearance of early erythroid precursors. Support for the presence of the Ta determinants on granulocyte-macrophage committed stem cells was provided by the inhibition of granulocyte colony formation in agar cultures following preincubation of normal bone marrow with antiserum and complement.
Cross absorptions with purified preparations of immature cells provided evidence for the close similarity of the antigenic determinants on both myeloblasts and B cells. A 28,000-37,000-dalton bimolecular complex obtained from myeloblast membranes contained the Ta determinants and was similar to that obtained from peripheral blood B cell membranes. Considerable interest has recently been directed to the membrane glycoproteins that contain the major antigenic determinants that characterize the B lymphocyte and aid in distinguishing these cells from T lymphocytes. These B cell components were initially recognized through alloantibodies contained in postpartum sera (1) and more recently with heteroantisera raised against purified preparations isolated from B cell membranes by enzyme (2, 3) or detergent (4) solubilization. This system of lymphocyte determinants primarily expressed on B cells has many analogies to the murine I-region antigen (Ia) system and thus has been termed "Ia-like"; however, for simplicity the term "Ta" will be used in this paper. As (4, 5) . However, from the initial studies it was clear that certain nonlymphoid cells bore similar antigenic determinants (1) .
Evidence that human Ia antigens characterize other types of bone marrow-derived cells was provided by their detection on peripheral blood monocytes (1, 4) and on the majority of cells from the blood of patients with acute myelogenous leukemia (AML) (3, 4, 6) even though the antigen was undetectable on circulating polymorphonuclear leukocytes. Among blood leukocytes from patients with chronic myelogenous leukemia (CML), the number of cells reported to have la antigens varied from low (3, 4) to absent (6) , and the myeloid elements of normal bone marrow have been reported to lack these determinants (6) .
An approach to the delineation of the variable expression of Ta antigens in myeloid leukemias was afforded by the preliminary finding that conventional Ficoll-Hypaque centrifugation of leukemic blood resulted in the separation of a relatively enriched preparation of antigen-bearing cells from those that lacked the immunofluorescent staining reaction (4) . In the present study, myeloid cell populations were fractionated on multistep discontinuous density gradients, thus achieving high degrees of purification of the Ta antigen-bearing cells. These were studied for the possiblity that the expression of the Ta antigens was restricted to early granulocytic precursors, and that, furthermore, the antigenic determinants were not limited to the myelogenous leukemic state but might be found at an analogous early stage of differentiation on a small number of normal marrow cells in the myeloid series. Inhibition of granulocyte-monocyte committed stem cell (CFU-C) pro NY) in water with a density (p) of 1.15-1.16 g/ml (200) was diluted with water to make each of the various densities used. One tube was underlayered in succession with 6-ml volumes of FicollHypaque of p 1.05, 1.06, and 1.07 g/ml, by using a syringe pump (Sage Instruments, Cambridge, MA). A second tube was underlayered with 1.07, 1.08, and 1.09 g/ml layers, whereas a third received 1.09, 1.105, and 1.12 g/ml layers. The fourth received only 6 ml of p 1.12 g/ml. The tubes were centrifuged at 1200 X g for 45 min at 20°. The lowest density layers of tubes two and three were heterogeneous in cell density and were discarded. The single 1.12-g/ml density layer in the fourth tube was used to recover over 98% of the leukocytes. It was the source of unseparated leukocyte preparations.
The cell layers concentrated at each density interface were aspirated from the surface and washed once with a solution of 1% bovine serum albumin in phosphate-buffered saline, pH 7.2. The cells in each fraction were counted to determine the yield, and differential counts (Wright's stain) were made after cytocentrifugation. Ia-Specific Antisera. Ia alloantigens were detected with a panel of four well-defined B cell-specific pregnancy or transplantation sera, selected as described (1, 4) . The B lymphocytes of over 95% of individuals tested reacted with at least one of these sera by indirect immunofluorescence. Two varieties of antisera were prepared against human Ia alloantigens isolated from B-type lymphoid line cells. For antiserum 1, a previously published procedure was followed involving detergent solubilization of B cell line membrane followed by gel filtration and identification of the fractions containing Ia alloantigen by cytotoxicity inhibition (4). These fractions were used as the immunogen. For antiserum 2, the fractions containing the alloantigens were further purified (5) by polyacrylamide gel electrophoresis with sodium dodecyl sulfate (7). The 65,000 dalton band containing the activity was used as the second immunogen (5). This band dissociated into 28,000 and 37,000 dalton subunits at 1000. Procedures used to obtain and define the Ia antigen specificity of these antisera have been described (4) .
Immunofluorescence. Antisera 1 and 2 were used as F(ab')2 fragments conjugated to tetramethylrhodamine isothiocyanate in direct fluorescence (4) . Indirect fluorescence was studied with the panel of four broadly reactive Ia alloantigen-specific pregnancy sera. Development of indirect immunofluorescence and the remainder of the procedures were performed as described (4), with the modification that procedures were performed at 4°. The results obtained with the serum yielding the highest extent of staining were taken as the number of cells bearing Ia alloantigens.
Granulocyte Colony Inhibition. Colony-forming cells were obtained from normal bone marrow and enriched on a bovine serum albumin gradient (1.07 g/ml) (8) Multistage density gradient analysis resulted in a marked parallel enrichment in the p < 1.06 g/ml fraction of myeloblasts and promyelocytes along with cells staining with the anti-Ia reagents (Tables 1 and 2 ). An average of 3% of applied cells was recovered in the p < 1.06 g/ml fraction. The percentage of Ia-staining cells ranged from 6 to 85 with resultant enrichments of up to 300-fold over levels in unseparated samples. By phase microscopy, it was apparent that the vast majority of the fluorescence-stained cells were myeloblasts, with a small but variable percentage of positive promyelocytes (Fig. 1) . The intensity of fluorescence staining of the early leukocyte forms ranged from strong to barely perceptible and usually was linear in character without having a speckled or patched distribution.
A minor fraction of the myeloblasts were negative (Fig. 1) ( Table 2 ). Approximately one-third of the myeloblasts in the patient with AGMM had Ia antigens. In both CML and AGMM patients, the fractions of higher density contained cells of progressively greater maturity (Table 1) . These accounted for 90 to over 99% of the cells applied to-the gradients. Only an infrequent promyelocyte or myelocyte had Ia antigen in these fractions (Table 1 ; Fig. 1) .
AML Leukocytes. The high percentage of myeloblasts in peripheral blood from patients with AML were nearly all brightly stained by direct or indirect fluorescence with the anti-Ia systems. Up to 90% of the applied cells were found in the p < 1.06 g/ml fraction (Table 2) although, unlike the CML findings, Ia antigen bearing myeloblasts also comprised 2-10% of the less numerous cells in the 1.07 and 1.08 g/ml fractions. interpretation. The more mature normoblasts were found in the fractions of higher density and these clearly lacked the Ia determinants. Because lymphocytes and monocytes express Ia antigens, special attention was given to their exclusion from the analyses. Wright-stained preparations confirmed that essentially all of the lymphoid cells were small or medium-sized lymphocytes and that monocytes were predominantly mature and latex-ingesting; thus, both cell types could be readily recognized under phase miscroscopy conditions. Furthermore, after staining for the presence of Ia antigens, 93-98% of the Ia-positive cells with blast or unclassifiable morphology did not form sheep erythrocyte-rabbit IgM antibody-complement (EAC1-3b) rosettes, under conditions such that virtually all Ia-positive B lymphocytes and monocytes formed rosettes.
Granulocyte-monocyte colony formation by precursor cells that are enriched in low density fractions of normal bone marrow was inhibited by pretreatment with anti-Ia antiserum 2 in the presence of complement. granulocyte-monocyte differentiation was provided by CFU-C inhibition. These antigenic determinants closely resembled the Ia antigens found on the surface of the B lymphocyte; cross absorption experiments provided evidence of the antigenic relationship. In addition, the Ia determinants of the myeloblast were present as a bimolecular complex, the components of which had apparent masses of 28,000 and 37,000 daltons. This complex was similar to that obtained from peripheral blood B cell membranes. Moreover, the Ia determinants on myelogenous leukemic cells also included those portions responsible for alloantigenic variation, as has been previously documented (4) .
The multistage density separation procedure used in the present study had as its primary advantage the production of cell fractions containing 10-to 300-fold higher concentrations of myeloblasts and promyelocytes than were found in the unseparated blood or marrow. Indeed, in some instances myeloblasts not found in unseparated peripheral blood from leukemia patients were only evident subsequent to their concentration. This enriching procedure also permitted the parallel use of conventional hematologic stains as a supplement to identification by phase microscopy. In addition, the progressive increase in cell density during granulocyte differentiation made it possible to determine that the complement receptors characteristic of the mature granulocyte appeared at the stages of metamyelocyte or myelocyte after the disappearance of Ia antigens (13) . The findings of this study also provided an interpretation of the previously reported undifferentiated blast-like forms in fetal hematopoietic tissue that bear Ia determinants (4). However, in this respect the present observations that Ia antigens were found on cells that appear to be early erythroid precursors were of particular relevance because of the dominance of erythro- (20) and the variation in expression of Ia determinants on circulating monocytes presages their absence from most macrophages. One implication of these findings is that the progenitor hematopoietic stem cell itself expresses Ia determinants. Further support for this was provided by the specific inhibition of CFU-C progenitor cells by extremely small quantities of anti-Ia serum. Conceptually, the presence of Ia determinants on stem cells further serves to unify the spectrum of Ia-positive leukemias originating from descendants of this common stem cell and includes the lymphocytic, myelogenous, monocytic, and their related varieties (4). However, as with the peripheral blood T 
